News

Clinical Trials Arena57m

First subject enrolled in Marea’s Phase I trial for acromegaly treatment

Marea Therapeutics has enrolled the first subject in the MAR-201 Phase I trial of MAR002, aimed at treating acromegaly.
Clinical Trials Arena2h

Newron randomises first subjects in Phase III programme for schizophrenia

Newron has randomised the first participants in its ENIGMA-TRS 1 Phase III programme of evenamide for treatment-resistant ...
Clinical Trials Arena20h

Perioperative Padcev and Keytruda improves survival in MIBC

In the Phase III trial, the combination of Padcev and Keytruda improved event-free survival and overall survival in MIBC.